Valeo Pharma Announces Upsize of Previously Announced Bought Deal Private Placement of Convertible Debentures to $15 Million With Concurrent $10 Million Private Placement From Investissement Quebec NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS ...

Valeo Pharma annonce un placement privé par voie de prise ferme de 10 millions $ de débentures convertibles et un placement privé concomitant de 10 millions $ d’Investissement Québec CE COMMUNIQUÉ NE DOIT PAS ÊTRE TRANSMIS AUX FILS DE PRESSE AMÉRICAINS OU DIFFUSÉ AUX ÉTATS-UNIS. LE NON-RESPECT DE CETTE RESTRICTION PEUT CONSTITUER UNE VIOLATION DES LOIS SUR LES VALEURS MOBILIÈRES...

Valeo Pharma Announces $10 Million Bought Deal Private Placement of Convertible Debentures With Concurrent $10 Million Private Placement From Investissement Quebec NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS ...

Valeo Pharma Announces $10.0 Million Bought-Deal Public Offering of Units NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES MONTREAL, June 08, 2021 (GLOBE NEWSWIRE) -- Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or...

Valeo Pharma Announces Short Form Prospectus Unit Offering and Refiling of Its Condensed Consolidated Interim Financial Statements and Related MD&A NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES MONTREAL, May 01,...